Metraipolis › archive › dc_f562154b6477
Predicting tumour and organ dose in α-radiopharmaceutical therapy: a 89Zr-based dosimetric approach for 225Ac — Europe PMC PMID:42455315
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42455315
- DOI
- 10.1007/s00259-[numero omesso]-x
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T06:38:36.912Z
- SHA-256 of the archived text
20da5e5eccaf2e3141de2ced8d5be6ca259875611bb547d1e2508b1227fb678f- Stable URL of this page
https://metraipolis.com/documento/dc_f562154b6477
How to cite
Predicting tumour and organ dose in α-radiopharmaceutical therapy: a 89Zr-based dosimetric approach for 225Ac — Europe PMC PMID:42455315 — Europe PMC (en), https://europepmc.org/article/MED/42455315 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f562154b6477 (Metraipolis archive dc_f562154b6477, sha256 20da5e5eccaf2e3141de2ced8d5be6ca259875611bb547d1e2508b1227fb678f)
BibTeX
@misc{dcf562154b6477,
title = {Predicting tumour and organ dose in α-radiopharmaceutical therapy: a 89Zr-based dosimetric approach for 225Ac — Europe PMC PMID:42455315},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42455315},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f562154b6477; sha256 20da5e5eccaf2e3141de2ced8d5be6ca259875611bb547d1e2508b1227fb678f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42455315. Agents can read the archived copy with the MCP tool read_document.